Context for peptide antibiotic biosynthesis
Antibiotic-producing bacteria and fungi show remarkable versatility in fashioning simple building blocks from primary metabolism into complex scaffold architectures with specifically arrayed functional groups to interact with particular targets in susceptible neighboring microbes (1, 2) . This is particularly notable in the economic utilization of malonyl-and methylmalonyl-CoA monomer units to make remarkably diverse polyketide frameworks as noted in two of the reviews in this thematic series, covering the macrocyclic erythromycin family and the polycyclic aromatic tetracyclines (see X and Y, this issue).
Parallel logic and machinery has evolved to use amino acids to elaborate peptide-based antibiotics (3-5). The nonribosomal peptide synthetase (NRPS) assembly lines are famous for turning out clinically important antibiotics, including the !-lactams (penems, cephems, carbapenems) (6) and the glycopeptides of the vancomycin family (7, 8) . More recently the nonribosomally derived lipo-depsipeptide daptomycin (9) has achieved notable clinical success in treatment of bacterial infections, as noted in a third minireview in this series (see Z, this issue).
A counterpoint strategy to these RNAindependent biosyntheses of peptide-like compounds involves ribosomal proteins that are processed posttranslationally to antibiotic peptides (4,5). While perhaps less well known than the NRPS-assembled peptide antibiotics, the ribosomal antibiotic peptides are widely distributed throughout prokaryotes; multicellular eukaryotes including humans also turn out large quantities of ribosomallyencoded defensins for innate immunity (10). The focus of this minireview is on ribosomal peptide antibiotics that have undergone more extensive processing than just the proteolytic removal of leader peptides (11). These are peptide antibiotics that have undergone posttranslational morphing of side chains and backbones to turn hydrolytically labile and acyclic floppy peptides into conformationally rigid architectures that are protease resistant. In this class fall the lantibiotics (12,13) such as nisin, long used in food preservatives, the thiazole-and oxazole-containing E. coli ! #! antibiotic peptide microcin B17 that targets DNA gyrase (14, 15) and the recently codified cyanobactin family (16, 17) . But the pieces de resistance for iterative posttranslational sculpting of peptide frameworks are the thiazolyl peptide antibiotics, produced by many gram-positive bacteria.
The thiazolyl peptide antibiotic family
The characteristic features of the thiazolyl peptide antibiotic class are a central pyridine/tetrahydropyridine ring, with up to three thiazolyl substituents at the 2, 3, and 6 positions of the central heterocycle to yield a rigid tetracyclic core with propeller-shaped architecture ( Figure 1A ). For review, see Bagley, et al. 2005 (18) . In members with the central nitrogen ring at the pyridine oxidation state (e.g. thiocillins, Figure 1B ) the peptide chain runs as a macrocyclic loop between the thiazole rings from the 3-to the 2-position of the pyridine. The chain then exits from the thiazole at the 6-position and terminates 2-4 residues downstream (19) (20) (21) (22) (23) (24) (25) . When the central ring is in the tetrahydropyridine oxidation state (e.g. in thiostrepton, Figure  1C ), the upstream peptide chain (the pre-or leader sequence) of the nascent peptide precursor is still attached at the 4-position of the pyridine. Some members of the thiostrepton subfamily have a second macrocyclic loop, utilizing this upstream peptide for modifications including macrocyclization and additional rigidification (26-29).
There are close to 100 members of the thiazolyl peptide antibiotic family isolated to date (18), beginning with Micrococcin, isolated from Oxford sewage in 1948 (30), with new isolates reported as recently as 2009 (31). Structure determination was historically challenging until sophisticated NMR methodology arrived. Total syntheses of a small number of this class reflect heroic efforts on the part of the synthetic community (32-40) but are not likely to be practical routes if large quantities would be needed, leaving fermentation as the practical manufacturing option.
Two classes of bacterial targets
As might be expected for antibiotics of molecular weight in the 1100-1200 Da range, the thiazolyl peptides do not get past the outer membrane barriers of gram negative bacteria but typically have submicromolar potencies against gram positive bacteria. They block bacterial protein synthesis selectively as will be reviewed below but have not achieved human clinical success due to twin failings of poor solubility and unfavorable pharmacokinetics.
Thiazolyl peptide compounds with antibiotic activity target consecutive steps of bacterial translation elongation (for a review of translation elongation, see Agirrezabala and Frank, 2009 (41) ). Molecules such as thiostrepton, thiocillins Figure 1B -C) and nosiheptide ( Figure 1D ) have been known for decades to bind to the 50S ribosomal subunit; resistance-generating mutations in particular loops of 23S rRNA and residues in large ribosomal protein subunit L11 allowed initial target site mapping (42-53). The recently determined X-ray structures of the 50S ribosomal subunit, with thiostrepton and nosiheptide bound show the precise interaction of the trithiazolyl pyridine core and macrocyclic loops with the 23S rRNA/L11 protein interface (54). This region of the ribosome constitutes part of the GTPase activating center (GAC), which is responsible for the GTP/GDP cycling required to coordinate the events of bacterial translation. Binding of the antibiotics in this region blocks productive docking of two GTPase elongation factors, EF-G and EF-Tu, responsible for translocation of the A-site tRNA into the ribosomal P-site and subsequent AA-tRNA delivery to the vacated A-site, respectively (43, (55) (56) (57) (Figure 2A ).
On the other hand the subfamily of thiazolyl peptides represented by GE2270 ( Figure 1F ) (58-60) and thiomuracin (61) congeners block protein synthesis at a prior step by tight binding to the EF-Tu conditional GTPase/chaperone that ferries aminoacylated tRNAs to the ribosome. X-ray analyses ( Figure 2B ) show that the GE2270 binding site overlaps with that of Phe-tRNA and thereby ! $! blocks its binding (62) (63) (64) (65) . One of the unsolved questions in this area of science involves determining which factors direct a thiazolyl peptide antibiotic to the 50S subunit vs. EF-Tu and whether one could engineer a hybrid scaffold that could hit both targets. Because the structures have been so complex and the total syntheses so long and difficult, essentially no structure-activity chemical relationships have been explored around this question.
Biosynthesis: Ribosomal or Nonribosomal
For many years the logic and machinery of the biosynthesis of this antibiotic class remained obscure. The key features to be explained include: 1) the timing and mechanism of dehydroalanine (DhA) and dehydrobutyrine (DhB) residue formation, 2) the timing and mechanism of thiazole and oxazole heterocycles, and 3) the construction of the central (tetrahydro)pyridine ring. On the one hand, it is known that thiazoles can be formed by NRPS assembly lines (66-70) and a publication in 2001 argued for NRPS machinery in production of micrococcin P1 (in the thiocillin class) by Staphylococcus equorum (71). On the other hand, dehydration of Ser side chains to DhA and Thr to DhB has been elucidated in detail for the posttranslational processing of nisin and other lantibiotics that are ribosomal peptides (12, (72) (73) (74) (75) . Analogously, microcin B17 arises from a ribosomally generated precursor peptide (hereafter, prepeptide) where the leader sequence is a crucial recognition element for a set of thee enzymes that convert four Cys residues to thiazoles and four Ser residues to oxazoles (66, (76) (77) (78) (79) . More recently the work of Eric Schmidt and colleagues showed that the 100 or so cyanobactins, cyclic peptides with posttranslationally generated heterocyclic rings, were similarly ribosomal in origin (16, 17) .
Thus the stage was set, in the era of a thousand sequenced bacterial genomes, for both genome mining and directed cloning approaches to definitively rule in the ribosomal paradigm for this antibiotic class. Four groups, publishing within a one month period early in 2009 (61,80-82) , reported genes encoding short prepeptides and adjacent posttranslational processing enzyme candidates for thiomuracin, GE2270 (Nonomurea strains), thiostrepton, siomycin A (streptomyces strains), and several thiocillin variants (Bacillus cereus). Subsequently, two additional gene clusters for nosiheptide (83) and for cyclothiazomycin (84) have since been reported, validating the general organization of the clustering of the structural gene for a prepeptide and genes for tailoring enzymes to convert the prepeptide to the mature antibiotic.
The approach we took (80) with thiocillin was to assume the DhB residues at positions 4 and 13 came from threonines, the six thiazoles from cysteines, and the central pyridine from two DhA residues, the last a hypothesis put forth by Bycroft (19) and then refined by Floss (85, 86) . As shown in Figure  3A , this rational deconvolution would turn thiocillin back into a fourteen-residue peptide precursor. We then scanned the bacterial genome database and found an exact match of these 14 residues at the C-terminus of a 52-residue ORF in a Bacillus cereus genome (ATCC 14579). We then validated that this strain was a thiocillin producer that generates a set of eight variants.
A complementary approach, design of degenerate PCR primers to match anticipated prepeptide coding sequence or one of the cyclodehydration enzymes, allowed cloning of the thiostrepton (81,82), thiomuracin (61) and nosiheptide (83) clusters. The gene cluster organization for all these thiazolyl peptides is remarkably conserved: a prepeptide gene, followed by a suite of genes encoding posttranslational maturation enzymes and export pumps, and in some clusters predicted self-resistance genes (61,80-84)
A cascade of posttranslational modifications
Analysis of the thiocillin biosynthetic gene cluster from B. cereus ATCC14579 reveals four identical copies of the prepeptideencoding gene (tclE-H) followed by seven/eight genes ( Figure 3B -C) which are predicted to have the desired features for a posttranslational cascade, including a pair of ! %! genes homologous to lantibiotic processing enzymes (tclK,L) which could make DhA at positions 1 and 10 and DhB at positions 4 and 13 ( Figure 3A) . Two microcin B17 operon homologs (tclJ,N) could turn six Cys side chains at positions 2, 5, 7, 9, 11, 12 into thiazolines by cyclodehydation, followed by oxidation to the heteroaromatic thiazoles ( Figure 4A-B) . The remaining ORFs encode likely candidates for catalyzing hydroxylation of Val6, O-methylation of Thr8 and oxidative decarboxylation of Thr14. These three enzymes appear to act stochastically, yielding 2 3 = 8 thiocillin variants, differing in the modification state of Val6, Thr8, and Thr14, but otherwise containing the same trithiazolyl pyridine core.
The eighth ORF, tclM in the thiocillin cluster, is a candidate for the enzyme that may catalyze cyclization of DhA1 and DhA10 (derived from Ser1 and Ser10) to the pyridine ring. Nothing is known yet about timing or intermediates although this is probably the central mechanistic question in assembly of the scaffold of this antibiotic class. If the process were to be concerted it would constitute a 4+2 type of aza-Diels Alder cyclization ( Figure 4C ), an as yet undetected class of biochemical transformation (87). By the end of the morphing process for enzymatic conversion of the 52-mer prepeptide into the mature scaffold of thiocillin, thirteen of the fourteen amino acids have undergone modification and 14 posttranslational enzymatic steps have occurred. This is typical for the other subfamilies of the thiazolyl peptide antibiotics. In the thiostrepton case, additional modifications are required to build the second conformation-restraining macrocyclic loop, including fashioning a bicyclic quinaldic acid spacer from tryptophan and inserting it into the peptide chain ( Figure 1C; (81,82) . Likewise, the secondary macrocycle of nosiheptide also contains a tryptophan-derived bicyclic ring system, in this case, indolic acid ( Figure 1D; (18,83) ).
The cyclothiazomycin gene cluster (84) reveals a 60-residue prepeptide whose 18 C-terminal amino acids get modified to a macrobicyclic scaffold ( Figure 1G ) with two notable variant features: first, the central pyridine has only one thiazole ring attached while the other two attached residues are Asn2 and Ala10 indicating that the pyridine ring formation does not require the maturing peptide chain to have been pre-constrained by three thiazoles; second, there is an unusual tertiary thioether bridge between what had been Ser5 and the C-terminal Cys18, perhaps arising from dehydrative conversion of Ser5 to DhA5, Michael addition by the thiol side chain of Cys18, and rearrangement to the observed alpha thiol Ala5 -Cys18 linkage. Cyclothiazomycin is not a protein synthesis inhibitor but rather an inhibitor of plasma renin (88-90), presumably reflecting a distinct architecture around the pyridine core, not recognized by EF-Tu or the large ribosomal subunits.
Genetic approaches to structure and activity of thiocillins
Because of the tractability of B. cereus to genetic manipulations, we have undertaken initial structure activity studies in vivo by manipulating the sequence of the 52mer prepeptide at the chromosomal level. To that end, a clean knockout of the four identical genes encoding the prepeptide substrate, tclE-H, was generated by double crossover homologous recombination, abolishing thiocillin production (91). Then antibiotic production was restored by re-introduction of a single copy of the wild type tclE gene into the chromosome, setting the stage for introduction of mutant forms of the tclE gene. Only limited studies have been conducted on changes in the leader peptide region (residues -1 to -38) since initial truncations led to loss of thiocillin production (Acker and Walsh, unpublished data); instead our efforts have focused on residues 1-14, retained in the mature antibiotic scaffold.
Of the 14 residues, only Thr3 is unmodified in the mature antibiotic, suggesting all other sites may be important in maturation. As an initial probe of the importance of side chains, alanine scanning was effected by replacement of each of the 14 residues individually. Production and ! &! posttranslational processing of 11 of the 14 alanine mutants was observed; no products were detected when Ser1, Ser10 or Cys11 were replaced by Ala ( Figure 4D ; (91,92). It was anticipated that the Ala1 and Ala10 mutants would be incompetent to form the central pyridine core. Lack of product from Ala11 could implicate that formation of a thiazole from Cys11 is an essential step in generation of the trithiazolyl pyridine framework of the mature antibiotics. All eleven of the single Ala mutants still had the central pyridine intact. The C2A and C9A mutants had bithiazolyl pyridine cores rather than the trithiazolyl pyridine core and had lost antibiotic activity, suggesting the propeller architecture of the central core and the directing effect on the macrocyclic peptide loop (residues 3-8) were essential for recognition by the 50S ribosomal subunit. The alanine scan also revealed that activity was attenuated when the thiazoles arising from Cys5 and Cys7 were replaced by Ala5 and Ala7, presumably a result of reducing the conformational rigidity in the macrocyclic loop. Also Ala3 and Ala4 replacements were inactive, indicating the Thr3-DhB4 sector of the mature thiazolyl peptide was important in binding to the ribosome target ( Figure 4D ; (54, 91, 92) .
Since one of the limitations of the thiazolyl peptide antibiotic class in treating bacterial infections in humans is poor solubility, we examined whether the tcl posttranslational machinery could handle Lys3, Lys6 and Lys8 as replacements for Thr, Val and Thr, respectively; the trithiazolyl pyridine scaffolds were produced, in lesser quantities, but antibiotic activity was not maintained (91). The same was true when negatively charged Asp side chains were used at positions 3 and 6: the trithiazolyl pyridine core was formed but the antibiotic activity was reduced at least two logs in potency.
One other set of mutants in the tclE prepeptide gene involved replacement of each of the six Cys residues with Ser. Three of the Cys residues, at positions 2, 9, and 11, flank the central pyridine ring in the propeller array. Cys5 and 7 are in the macrocyclic loop, providing rigidifying conformational restraint, while Cys12 becomes part of the bithiazole moiety in mature thiocillin scaffolds.
The corresponding Ser replacements test the partition of each Ser residue between two posttranslational processing alternatives. One is the lantibiotic type pathway (tclK,L), involving transient O-phosphorylation and then elimination of P i to yield the olefinic DhA as happens in processing of Ser1 and Ser10. The other (tclJ,N) is the microcin-type cyclodehydration to oxazoline and aromatizing oxidation to the oxazole ring. Therefore, a Cys to Ser replacement could generate four possible alternatives: 1) no modification of the CH 2 OH serine side chain; 2) DhA formation; 3) cyclodehydration and accumulation of the oxazoline ring; 4) dehydrogenation of oxazoline intermediate to the stable oxazole ring. For example the C2S mutant yielded the unmodified Ser and the oxazoline while oxazoline and oxazole derivatives were detected for the C12S mutant. Notably absent were any products from the C11S mutant, reminiscent of the absence of maturation of the C11A mutant, consistent with a special role for the thiazole at residue 11 in the trithiazolyl pyridine core construction.
Outlook
A major goal for engineering of the posttranslational morphing of prepeptides into the various subgroups of thiazolyl peptide antibiotics is to improve the aqueous solubility and unfavorable pharmacokinetic properties that to date have obviated their clinical development for human infections by gram positive bacterial pathogens. Because of the structural complexity and lengthy total synthetic routes to the fully mature scaffolds, very few medicinal chemistry efforts have been reported, mostly involving reconstruction of the C-terminus to make more soluble variants (93-96). Also, it appears that fragments of the core have lost orders of magnitude of antibiotic potency (97), consistent with requirement for the full architectural array for potent bacterial protein synthesis target recognition.
! '!
Thus, reprogramming both the prepeptide sequence and the tailoring specificity and capacity of the cascade of affiliated posttranslational modification enzymes offers promise to explore what resculpting of the scaffold can be engineered and then which modifications retain full antibiotic potency. Although initial in vivo efforts to engineer more hydrophilic thiocillins have been achieved, the Lys and Asp side chains so far introduced do not retain antibiotic activity (91). However, producer organisms can hydroxylate and/or glycosylate selected thiazolyl peptide antibiotics (22,29,98-100) so it will be of interest to move those tailoring enzymes to heterologous thiazolyl peptide producers and examine the outcomes for increased aqueous solubility and potency retention.
In turn, reconstitution of the maturation steps by in vitro studies with purified enzymes will help to establish the timing of multiple dehydro amino acid formations (4 in thiocillins), of heterocyclization of Cys to thiazoles (6 in thiocillins) and of the dimerization of two Ser-derived DhA residues to a dihydropyridine ring, with subsequent redox adjustment, up to the hetroaromatic pyridine and down to the tetrahydropyridine found in thiostrepton. Which, if any, of the thiazole rings must form first (perhaps to induce a kinked conformation in the prepeptide backbone) to bring DhA1 and DhA10 in sufficient proximity to undergo the proposed aza-Diels-Alder cyclization, is yet unknown but we have cited evidence that Cys11 cannot be replaced in thiocillin maturation.
Of particular interest will be deciphering the parameters that control regiochemistry of pyridine ring formation. In both the thiocillin and thiostrepton subclasses, Ser1 and Ser10 end up, after dehydration, as the framework of the pyridine/tetrahydropyridine ring with an intervening 26-atom peptide loop. In GE2270, the core pyridine is instead formed from Ser1 and Ser11 while in berninamycin the pyridine most likely derives from Ser1 and Ser13. Whether a single producer such as B. cereus ATCC14579 can carry out such distinct regiochemistries of cyclization, based solely on different prepeptide sequences with altered Ser spacing, or whether putative "aza-DielsAlderases" in each organism are specific for 26-, 29-, or 35-membered rings, or other size variants remains to be explored in "mix and match" studies. In this context the 29-membered GE2270 does not hit the 50S ribosome but rather EF-Tu as its target, so it may be possible to redirect target selectivity by control of macrocyclic loop size. 
